They have only just started their phase 3. It's only going to have around 128 patients. Let's see how long it takes to enroll. I can't even find it in clinical trials.gov yet.
Meanwhile, we are looking at the big picture, teaming up with Vanderbilt University and going after all cause ARDS. Sure, I wish it was started already, but I am happy we're heading there with a top notch investigator...
Interesting MSC's Article, page-8
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |